NCT04967651

Brief Summary

The purpose of this study is to collect perioperative diagnosis and treatment information for cardiac surgery patients, collect blood samples for laboratory testing when necessary, and analyze the data to clarify the risk factors of pulmonary complications in patients undergoing cardiac surgery during the perioperative period. On this basis, a clinical early warning model for pulmonary complications after cardiac surgery will be developed to reduce the risk of pulmonary complications and even death in clinical practice.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 19, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

August 23, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

November 3, 2021

Status Verified

October 1, 2021

Enrollment Period

1.3 years

First QC Date

July 15, 2021

Last Update Submit

October 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The occurrence of postoperative pulmonary complications

    1 week after surgery

Study Arms (2)

Patients with pulmonary complications following cardiac surgery

Patients without pulmonary complications following cardiac surgery

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients aged 18 years or older who planned elective cardiac surgery under general anesthesia

You may qualify if:

  • Adult patients aged 18 years or older;
  • Elective cardiac surgery under general anesthesia

You may not qualify if:

  • Patients and their family members refused to be enrolled;
  • Patients unable to communicate due to language barriers such as dementia;
  • Patients admitted to ICU 24h before surgery;
  • Estimated duration of surgery less than 2 hours;
  • Patients died or discharged within 24 hours after surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wuhan Union Hospital

Wuhan, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

plasma

Central Study Contacts

Qingping Wu

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2021

First Posted

July 19, 2021

Study Start

August 23, 2021

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

November 3, 2021

Record last verified: 2021-10

Locations